APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

23 hedge funds and large institutions have $1.33M invested in Aptose Biosciences, Inc. in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$776K
2
SPC
2
Sigma Planning Corp
Michigan
$165K
3
UBS Group
3
UBS Group
Switzerland
$54.9K
4
TSS
4
Two Sigma Securities
New York
$12.5K
5
AC
5
Annandale Capital
Texas
$11K

Top Sellers

1
OP
1
ORG Partners
Indiana
$0
2
TWC
2
TD Waterhouse Canada
Ontario, Canada
$263
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$1K
4
Cetera Investment Advisers
4
Cetera Investment Advisers
Illinois
$7.9K
5
PCWA
5
Pacific Capital Wealth Advisors
California
$2
Name Holding Trade Value Shares
Change 		Shares
Change %
OP
26
ORG Partners
Indiana
– -$2.98K -133 Closed
Citigroup
27
Citigroup
New York
– -$1 – –
National Bank of Canada
28
National Bank of Canada
Quebec, Canada
– -$1 – –
1
2